Philippines Business News API

{
    "totalArticles": 316158,
    "articles": [
        {
            "id": "a6b85df3166b6aba61183ecd5d7c9ef0",
            "title": "AI Sector Growth Accelerates Past $26 Billion as Ruvi AI (RUVI) Launches New Features, Proprietary Models, and Ecosystem Upgrades",
            "description": "DUBAI, United Arab Emirates, May 30, 2026 (GLOBE NEWSWIRE) -- The AI training data market reached roughly $2.32 billion in 2026, up from $1.89 billion in 2025, and analysts project it toward $6.53 billion by 2031. Each major frontier AI lab now spends close to $1 billion per year on human-generated training data, with Scale AI at a reported $14 billion valuation.",
            "content": "DUBAI, United Arab Emirates, May 30, 2026 (GLOBE NEWSWIRE) -- The AI training data market reached roughly $2.32 billion in 2026, up from $1.89 billion in 2025, and analysts project it toward $6.53 billion by 2031. Each major frontier AI lab now spend... [4059 chars]",
            "url": "https://www.manilatimes.net/2026/05/31/tmt-newswire/globenewswire/ai-sector-growth-accelerates-past-26-billion-as-ruvi-ai-ruvi-launches-new-features-proprietary-models-and-ecosystem-upgrades/2355070",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/05/31/1078598.jpg",
            "publishedAt": "2026-05-30T18:05:29Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        },
        {
            "id": "736706fe9a0cc7ccd764c534bf662d98",
            "title": "ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026",
            "description": "¹⁷⁷Exploratory analysis showed favorable patient-reported quality of life outcomes and delayed time to deterioration in patients receiving ¹⁷⁷Lu-edotreotide Data build upon previously reported COMPETE efficacy results, adding patient-centered evidence for ¹⁷⁷Lu-edotreotide in GEP-NETsChicago, Illinois, May 30, 2026 -- ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced encouraging Health-Related Quality of Life (HRQoL) data from its Phase 3 COMPETE trial in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The data showed favorable and durable quality of life outcomes for patients receiving non-carrier-added (n.c.a.) ¹⁷⁷Lu-edotreotide (also known as ITM-11 or ¹⁷⁷Lu-edotreotide) compared to everolimus, a systemic standard of care treatment.",
            "content": "¹⁷⁷Exploratory analysis showed favorable patient-reported quality of life outcomes and delayed time to deterioration in patients receiving ¹⁷⁷Lu-edotreotide\nData build upon previously reported COMPETE efficacy results, adding patient-centered evidenc... [5305 chars]",
            "url": "https://www.manilatimes.net/2026/05/31/tmt-newswire/globenewswire/itm-announces-phase-3-compete-patient-reported-quality-of-life-data-with-nca-lu-edotreotide-itm-11-vs-everolimus-at-asco-2026/2355064",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/05/31/1078590.png",
            "publishedAt": "2026-05-30T17:05:17Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        },
        {
            "id": "a6e27c6fbb4e4c269e19749b4d0231cf",
            "title": "Global Times: China demonstrates remarkable ability to set a long-term vision and actually execute it",
            "description": "Global Times: Expert Chandran Nair sees China's 15th Five-Year Plan as a global stability anchor, prioritising rural growth and sustainability.",
            "content": "Global Times: Expert Chandran Nair sees China's 15th Five-Year Plan as a global stability anchor, prioritising rural growth and sustainability.\nBeijing, CHINA, May 30, 2026 (GLOBE NEWSWIRE) -- 2026 marks the commencement of China's 15th Five-Year Pla... [7489 chars]",
            "url": "https://www.manilatimes.net/2026/05/31/tmt-newswire/globenewswire/global-times-china-demonstrates-remarkable-ability-to-set-a-long-term-vision-and-actually-execute-it/2355062",
            "image": "https://cdnx.premiumread.com/?url=https://www.manilatimes.net/theme_manilatimes/images/TMT_1920x1008.jpg&w=1920&q=100&f=webp&v=1",
            "publishedAt": "2026-05-30T16:45:15Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        }
    ]
}